Amgen Inc. sell Bank of America Co.
Start price
23.07.25
/
50%
€261.75
Target price
23.07.26
€222.32
Performance (%)
17.13%
Price
10.04.26
€299.30
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ currently has a performance of 17.13%. Dividends of €7.28 are taken into consideration when calculating the performance. This prediction currently runs until 23.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -0.795% | -0.795% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Corporation from $252.00 to $261.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat